KMID : 0613820220320070567
|
|
Journal of Life Science 2022 Volume.32 No. 7 p.567 ~ p.577
|
|
Development of Cell Therapeutics against Ischemic Vascular Diseases Using Mesenchymal Stem Cells: From Bench to Bed
|
|
Lee Eun-Ji
Park Shin-Hu Seo Jeong-Ho An Hyo-Gyung Nam Si-Hyun Kwon Sang-Mo
|
|
Abstract
|
|
|
Recently, the prevalence of ischemic diseases, such as ischemic heart disease, cerebral ischemia, and peripheral arterial disease, has been continuously increasing due to the aging population. The current standardized treatment for ischemic diseases is reperfusion therapy through pharmacotherapy and surgical approaches. Although reperfusion therapy may restore the function of damaged arteries, it is not effective at restoring the function of the surrounding tissues that have been damaged due to ischemia. Therefore, it is necessary to develop a new treatment strategy that can safely and effectively treat ischemic damage and restore the function of surrounding tissues. To overcome these limitations, stem cell-based therapy to regenerate the damaged region has been studied as a promising strategy for ischemic vascular diseases. Mesenchymal stem cells (MSCs) can be isolated from diverse tissues and have been shown to be promising for the treatment of ischemic disease by regenerating damaged tissues through immunomodulation, the promotion of angiogenesis, and the secretion of various relevant factors. Moreover, new approaches to enhancing MSC function, such as cell priming or enhancing transplantation efficiency using a 3D culture method, have been studied to increase stem cell therapeutic efficacy. In this review, we provide various strategies by which MSCs are used to treat ischemic diseases, and we discuss the challenges of MSC transplantation, such as the differentiation, proliferation, and engraftment of MSCs at the ischemic site.
|
|
KEYWORD
|
|
Ischemic heart disease, Ischemic stroke, Mesenchymal stem cells, Peripheral artery disease, stem cell therapy
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|